Helixgate

Helixgate

Uncategorized

Compass shares crash as ‘confounding’ survival data raise approvability questions for bispecific

Published

on

While tovecimig met the main goal of progression-free survival in a Phase 2/3 trial, it did not improve overall survival.

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Uncategorized

STAT+: More political interference at the FDA?

You’re reading the web edition of D.C. Diagnosis, STAT’s twice-weekly newsletter about the politics and policy of health and medicine. Sign up here to receive it in your inbox on Tuesdays and Thursdays.

This is a photo of a young RFK Jr. trying to ride a small rhino. Send news tips and RINO jokes to John.Wilkerson@statnews.com or John_Wilkerson.07 on Signal.

Former DOGE co-founder v. former state Covid-19 czar

Although most people whom DOGE fired from HHS probably don’t live in Ohio, they may feel a personal connection to the gubernatorial race there.

Continue to STAT+ to read the full story…

Read More

Published

on

You’re reading the web edition of D.C. Diagnosis, STAT’s twice-weekly newsletter about the politics and policy of health and medicine. Sign up here to receive it in your inbox on Tuesdays and Thursdays.

This is a photo of a young RFK Jr. trying to ride a small rhino. Send news tips and RINO jokes to John.Wilkerson@statnews.com or John_Wilkerson.07 on Signal.

Former DOGE co-founder v. former state Covid-19 czar

Although most people whom DOGE fired from HHS probably don’t live in Ohio, they may feel a personal connection to the gubernatorial race there.

Continue to STAT+ to read the full story…

Read More

Continue Reading

Uncategorized

Angelini inks $4.1B Catalyst buy to enter US rare disease market

Published

on

Catalyst Pharmaceuticals comes with a trio of approved drugs as Angelini Pharma expands its neuroscience offerings.

Continue Reading

Uncategorized

Gilead wipes out most of Arcellx workforce

Published

on

Gilead is laying off Arcellx employees in California and Maryland, with some cuts effective this year and the remainder happening in 2027.

Continue Reading
Advertisement

Trending